Spots Global Cancer Trial Database for camrelizumab + famitinib
Every month we try and update this database with for camrelizumab + famitinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer | NCT05042375 | Non-small Cell ... | camrelizumab + ... pembrolizumab camrelizumab | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer | NCT05042375 | Non-small Cell ... | camrelizumab + ... pembrolizumab camrelizumab | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
